Insider · CIK 0001845002
Marion Odence-Ford
Files at OPRX (OptimizeRx Corp). First filing Jan 11, 2024, latest Jan 11, 2024.
In brief
Marion Odence-Ford files SEC Form 4 as officer at OPRX (OptimizeRx Corp). Since Jan 11, 2024, Marion Odence-Ford has reported 0 open-market buys worth $0 and 1 open-market sell worth $61k, the latest filed on Jan 11, 2024.
A track record needs three past buys with six months of prices behind them; Marion Odence-Ford has 0, so none is measured yet.
The newest scored trade: sold $61k of OPRX on Jan 9, 2024, filed Jan 11, 2024, scored 12 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
OPRX: OptimizeRx Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 12Weak | OptimizeRx Corp | $61k 4,000 shares | -26% | +115% from low-22% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jan 9, 2024 | OPRX OPTIMIZERX CORP | 4,000 0.02% of outstanding | $53k | Jan 9, 2024 | none |
Transactions
Every row this insider has filed, 34 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 20, 2026 | OPRX OptimizeRx Corp | AGrant or award Common Stock | +57,600 | $0.00 | $0 | 148,007 | Aug 24, 2026 |
| Aug 21, 2026 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -1,529 | $7.71 | $12k | 90,407 | Aug 24, 2026 |
| Feb 11, 2026 | OPRX OptimizeRx Corp | MOption exercise Common Stock | +4,000 | - | - | 93,322 | Feb 13, 2026 |
| Feb 11, 2026 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -1,386 | $9.23 | $13k | 91,936 | Feb 13, 2026 |
| Feb 11, 2026 | OPRX OptimizeRx Corp | MOption exercise Restricted Stock Unitsderivative | -4,000 | $0.00 | $0 | 0 | Feb 13, 2026 |
| Dec 23, 2025 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -4,051 | $12.74 | $52k | 89,322 | Dec 23, 2025 |
| Dec 19, 2025 | OPRX OptimizeRx Corp | MOption exercise Common Stock | +3,928 | $0.00 | $0 | 94,526 | Dec 22, 2025 |
| Dec 19, 2025 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -1,153 | $13.51 | $16k | 93,373 | Dec 22, 2025 |
| Dec 19, 2025 | OPRX OptimizeRx Corp | MOption exercise Restricted Stock Unitsderivative | -3,928 | $0.00 | $0 | 3,928 | Dec 22, 2025 |
| Oct 3, 2025 | OPRX OptimizeRx Corp | MOption exercise Common Stock | +6,649 | $0.00 | $0 | 92,550 | Oct 7, 2025 |
| Oct 3, 2025 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -1,952 | $18.75 | $37k | 90,598 | Oct 7, 2025 |
| Oct 3, 2025 | OPRX OptimizeRx Corp | MOption exercise Restricted Stock Unitsderivative | -6,649 | $0.00 | $0 | 0 | Oct 7, 2025 |
| Aug 21, 2025 | OPRX OptimizeRx Corp | AGrant or award Common Stock | +15,625 | $0.00 | $0 | 85,901 | Aug 25, 2025 |
| Aug 21, 2025 | OPRX OptimizeRx Corp | AGrant or award Stock Optionderivative | +35,156 | $0.00 | $0 | 35,156 | Aug 25, 2025 |
| Dec 23, 2024 | OPRX OptimizeRx Corp | AGrant or award Common Stock | +41,408 | $0.00 | $0 | 68,638 | Dec 27, 2024 |
| Dec 23, 2024 | OPRX OptimizeRx Corp | AGrant or award Stock Optionderivative | +77,742 | $0.00 | $0 | 77,742 | Dec 27, 2024 |
| Dec 19, 2024 | OPRX OptimizeRx Corp | MOption exercise Common Stock | +3,927 | $0.00 | $0 | 28,383 | Dec 20, 2024 |
| Dec 20, 2024 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -1,153 | $4.75 | $5,477 | 27,230 | Dec 20, 2024 |
| Dec 19, 2024 | OPRX OptimizeRx Corp | MOption exercise Restricted Stock Unitsderivative | -3,927 | $0.00 | $0 | 7,856 | Dec 20, 2024 |
| Nov 8, 2024 | OPRX OptimizeRx Corp | MOption exercise Common Stock | +1,785 | $0.00 | $0 | 24,980 | Nov 12, 2024 |
| Nov 8, 2024 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -524 | $6.27 | $3,285 | 24,456 | Nov 12, 2024 |
| Nov 8, 2024 | OPRX OptimizeRx Corp | MOption exercise Restricted Stock Unitsderivative | -1,785 | $0.00 | $0 | 0 | Nov 12, 2024 |
| Mar 1, 2024 | OPRX OptimizeRx Corp | MOption exercise Common Stock | +771 | $0.00 | $0 | 14,499 | Mar 6, 2024 |
| Mar 1, 2024 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -268 | $15.95 | $4,275 | 14,231 | Mar 6, 2024 |
| Mar 1, 2024 | OPRX OptimizeRx Corp | MOption exercise Restricted Stock Unitsderivative | -771 | $0.00 | $0 | 771 | Mar 6, 2024 |
| Dec 19, 2023 | OPRX OptimizeRx Corp | AGrant or award Stock Optionderivative | +11,783 | $0.00 | $0 | 11,783 | Feb 21, 2024 |
| Dec 19, 2023 | OPRX OptimizeRx Corp | AGrant or award Restricted Stock Unitsderivative | +11,783 | $0.00 | $0 | 11,783 | Feb 21, 2024 |
| Feb 11, 2024 | OPRX OptimizeRx Corp | MOption exercise Common Stock | +4,000 | $0.00 | $0 | 15,114 | Feb 13, 2024 |
| Feb 11, 2024 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -1,386 | $15.39 | $21k | 13,728 | Feb 13, 2024 |
| Feb 11, 2024 | OPRX OptimizeRx Corp | MOption exercise Restricted Stock Unitsderivative | -4,000 | $0.00 | $0 | 16,000 | Feb 13, 2024 |
| Jan 9, 2024 | OPRX OptimizeRx Corp | SOpen-market sale Common Stock10b5-1 | -4,000 | $15.19 | $61k | 11,114 | Jan 11, 2024 |
| Nov 8, 2023 | OPRX OptimizeRx Corp | MOption exercise Common Stock | +1,785 | $0.00 | $0 | 15,638 | Nov 13, 2023 |
| Nov 8, 2023 | OPRX OptimizeRx Corp | FTax withholding Common Stock | -524 | $9.21 | $4,826 | 15,114 | Nov 13, 2023 |
| Nov 8, 2023 | OPRX OptimizeRx Corp | MOption exercise Restricted Stock Unitsderivative | -1,785 | $0.00 | $0 | 1,785 | Nov 13, 2023 |
Questions about Marion Odence-Ford
Answered from the filings on this page, as of the latest one.
Is Marion Odence-Ford buying or selling?
Not in the last 12 months. Marion Odence-Ford's latest open-market trade on SEC Form 4 was sold $61k of OPRX on Jan 9, 2024.
How did Marion Odence-Ford's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Marion Odence-Ford has 0.
Where does Marion Odence-Ford file Form 4?
Marion Odence-Ford has filed Form 4 at OPRX (OptimizeRx Corp) as General Counsel and CCO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.